07/03/2025
3:39 PM | Kiniksa Pharmaceuticals International (Issuer)
Levy Richard S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2025
3:39 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/16/2025
4:23 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2025
4:32 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
4:35 PM | Kiniksa Pharmaceuticals International (Issuer)
Quart Barry D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2025
3:39 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2025
4:46 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2025
3:50 PM | Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
3:53 PM | Kiniksa Pharmaceuticals International (Issuer)
Quart Barry D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
3:55 PM | Kiniksa Pharmaceuticals International (Issuer)
Popovits Kimberly J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
3:59 PM | Kiniksa Pharmaceuticals International (Issuer)
McCain Tracey L (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for KNSA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Kiniksa Pharmaceuticals International and its competitors with MarketBeat's FREE daily newsletter. |
06/05/2025
4:02 PM | Kiniksa Pharmaceuticals International (Issuer)
Malley Thomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
6:10 AM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2025
3:30 PM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2025
4:25 PM | Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2025
4:23 PM | Kiniksa Pharmaceuticals International (Filer)
| Form DEFA14A | |
05/22/2025
3:38 PM | Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2025
3:37 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/19/2025
4:16 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2025
3:39 PM | Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
4:32 PM | Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2025
4:13 PM | Kiniksa Pharmaceuticals International (Subject)
Patel Sanj K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/05/2025
3:47 PM | Kiniksa Pharmaceuticals International (Issuer)
Paolini John F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:49 PM | Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:50 PM | Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:52 PM | Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:53 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/05/2025
3:54 PM | Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
5:26 PM | Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
5:24 PM | Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2025
4:10 PM | Kiniksa Pharmaceuticals International (Subject)
Moat Ross (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/01/2025
4:11 PM | Kiniksa Pharmaceuticals International (Subject)
Ragosa Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/29/2025
3:15 PM | Kiniksa Pharmaceuticals International (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/29/2025
6:40 AM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2025
6:47 PM | BlackRock, Inc. (Filed by)
Kiniksa Pharmaceuticals International (Subject)
| Form SCHEDULE 13G/A | |
04/23/2025
3:31 PM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2025
3:44 PM | Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/21/2025
4:30 PM | Kiniksa Pharmaceuticals International (Filer)
| Form DEFA14A | |
04/16/2025
3:38 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/10/2025
3:39 PM | Kiniksa Pharmaceuticals International (Filer)
| Form PRE 14A | |
04/09/2025
3:41 PM | Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
A new rule goes live in July — and the banks are quietly cashing in (Ad) A little-known regulation quietly goes into effect this July.
And it's already being exploited by Wall Street and the Big Banks…
It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash.
Not stocks. Not real estate. And definitely not the U.S. dollar.
We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them. To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how |
04/09/2025
3:42 PM | Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
3:43 PM | Kiniksa Pharmaceuticals International (Issuer)
Paolini John F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
3:44 PM | Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
3:45 PM | Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2025
3:45 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/04/2025
5:57 PM | Kiniksa Pharmaceuticals International (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
| Form SCHEDULE 13G | |
04/03/2025
4:06 PM | Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2025
3:52 PM | Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/24/2025
3:35 PM | Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:48 PM | Kiniksa Pharmaceuticals International (Issuer)
Paolini John F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:49 PM | Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:50 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:51 PM | Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:52 PM | Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2025
4:53 PM | Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
4:29 PM | Kiniksa Pharmaceuticals International (Subject)
Ragosa Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2025
3:37 PM | Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
3:38 PM | Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
3:47 PM | Kiniksa Pharmaceuticals International (Subject)
Megna Michael R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2025
3:37 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/10/2025
4:13 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/25/2025
3:31 PM | Kiniksa Pharmaceuticals International (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/25/2025
3:15 PM | Kiniksa Pharmaceuticals International (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/25/2025
6:31 AM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
2:45 PM | Fairmount Funds Management LLC (Filed by)
Kiniksa Pharmaceuticals International (Subject)
| Form SCHEDULE 13G/A | |
02/10/2025
4:37 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/15/2025
3:42 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/13/2025
4:27 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/13/2025
6:34 AM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
3:45 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
4:17 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024
3:34 PM | Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2024
6:14 PM | Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
4:25 PM | Kiniksa Pharmaceuticals International (Subject)
Ragosa Mark (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2024
4:13 PM | Kiniksa Pharmaceuticals International (Subject)
Megna Michael R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024
4:50 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
3:32 PM | HHLR ADVISORS, LTD. (Filed by)
Kiniksa Pharmaceuticals International (Subject)
| Form SC 13G/A | |
11/13/2024
3:30 PM | Kiniksa Pharmaceuticals International (Subject)
Rubric Capital Management LP (Filed by)
| Form SC 13G/A | |
11/06/2024
3:11 PM | Kiniksa Pharmaceuticals International (Subject)
Patel Sanj K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/29/2024
3:14 PM | Kiniksa Pharmaceuticals International (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/29/2024
6:31 AM | Kiniksa Pharmaceuticals International (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/21/2024
3:11 PM | BlackRock, Inc. (Filed by)
Kiniksa Pharmaceuticals International (Subject)
| Form SC 13G | |
10/17/2024
3:35 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/15/2024
3:57 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/08/2024
4:29 PM | BAKER BROS. ADVISORS LP (Filed by)
Kiniksa Pharmaceuticals International (Subject)
| Form SC 13D/A | |
10/08/2024
4:08 PM | Boyd Meta Cantey (Reporting)
Kiniksa Pharmaceuticals International (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/08/2024
3:40 PM | Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/08/2024
3:14 PM | 667, L.P. (Reporting)
Baker Bros. Advisors LLC (0001580575) (Reporting)
BAKER BROS. ADVISORS LP (Reporting)
Baker Brothers Life Sciences LP (Reporting)
BAKER FELIX (Reporting)
BAKER JULIAN (Reporting)
Kiniksa Pharmaceuticals International (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/25/2024
3:39 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/23/2024
4:02 PM | Kiniksa Pharmaceuticals International (Subject)
Tessari Eben (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
The Next Commodity Crisis Just Got a Name: Silver (Ad) Elon's Next Market Move Could Send Silver Soaring
Every industry Elon Musk touches explodes—from Tesla to SpaceX to AI.
And now, whispers are growing that his next move could be in silver.
Why? Because silver is the lifeblood of EVs, solar panels, and AI tech. Smart money is already watching silver closely. |
09/04/2024
7:57 PM | Kiniksa Pharmaceuticals International (Issuer)
Megna Michael R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:51 PM | Kiniksa Pharmaceuticals International (Issuer)
Ragosa Mark (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:52 PM | Kiniksa Pharmaceuticals International (Issuer)
Paolini John F. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:53 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:55 PM | Kiniksa Pharmaceuticals International (Issuer)
Patel Sanj K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
7:42 PM | Kiniksa Pharmaceuticals International (Issuer)
Moat Ross (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
4:16 PM | Kiniksa Pharmaceuticals International (Subject)
Paolini John F. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/03/2024
4:17 PM | Kiniksa Pharmaceuticals International (Subject)
Moat Ross (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/29/2024
3:36 PM | Kiniksa Pharmaceuticals International (Issuer)
Tessari Eben (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
